Vaxcyte, Inc.
PCVX
Pozycja w akcjach
#2112
Vaxcyte, Inc. is a biotechnology firm in the clinical development stage,... Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.
Cena akcji
$63.40
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$9.72B
Zmiana (1 dzień)
-2.87%
Zmiana (1 rok)
49.56%
Kraj
US
Handel Vaxcyte, Inc. (PCVX)
Kategoria
Healthcare
EPS dla Vaxcyte, Inc. (PCVX)
EPS na dzień June 2026 TTM: $-7.64
Według najnowszych raportów finansowych i ceny akcji firmy Vaxcyte, Inc., obecny EPS (TTM) wynosi $-7.64. Na koniec roku 2023 firma miała EPS w wysokości $-4.14, wzrost w porównaniu do do EPS z roku 2022, który wynosił $-3.44.
Historia EPS dla Vaxcyte, Inc. od 2017 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $-7.64 | 101.05% |
| 2024 | $-3.80 | -8.21% |
| 2023 | $-4.14 | 20.35% |
| 2022 | $-3.44 | 78.24% |
| 2021 | $-1.93 | -35.02% |
| 2020 | $-2.97 | -78.94% |
| 2019 | $-14.10 | 73.65% |
| 2018 | $-8.12 | 67.77% |
| 2017 | $-4.84 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $17.32 | -326.70% |
US
|
|
| $-7.98 | 4.45% |
US
|
|
| $-5.29 | -30.76% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -463.09% |
NL
|
